Emerging therapeutic agents for lung cancer

Lung cancer continues to be the most common cause of cancer-related mortality worldwide. Recent advances in molecular diagnostics and immunotherapeutics have propelled the rapid development of novel treatment agents across all cancer subtypes, including lung cancer. Additionally, more pharmaceutical...

Descripción completa

Detalles Bibliográficos
Autores principales: Dholaria, Bhagirathbhai, Hammond, William, Shreders, Amanda, Lou, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148871/
https://www.ncbi.nlm.nih.gov/pubmed/27938382
http://dx.doi.org/10.1186/s13045-016-0365-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148871/
https://www.ncbi.nlm.nih.gov/pubmed/27938382
http://dx.doi.org/10.1186/s13045-016-0365-z

Ejemplares similares